Initiators, sponsors and partners
Apotekarsocieteten’s section for Regulatory Affairs/Kapitel Tre
Eva Lilienberg, Member of the Board/CEO
”The life science industry in Sweden is a great place to learn the regulatory work. Sweden has and has had large companies functioning as nurseries for many regulatory professionals. In addition, the Medical Products Agency takes on a lot of responsibility in the EU work and persons from their staff find their way out to pharma companies and vice versa. Sweden is also a small country where many people know each other and can share experiences on a network basis, e.g. through Apotekarsocieteten. Läkemedelsakademin also plays an important role, with courses that continuously develop people throughout working life. Skills development is needed, not only for individuals but also for the Swedish pharma industry. This is to maintain a strong position when the company structure is shifting towards a larger amount of smaller companies where it can be more difficult to build a broad expertise.”
Director of Continuing Professional Development Regulatory Affairs
Sandra Trost
Swedenbio
Jessica Martinsson, Director General & CEO
”Access to regulatory competence is crucial for all stages of drug development and market approval. For small companies the opportunity to get updated knowledge in an efficient and agile way is key and this program is filling these needs in a good way.”
Science Skills/MultiHelix
Ursula Hultkvist Bengtsson, Chairman of the Board/CEO
”Life science in Sweden needs both an addition of regulatory personnel (e.g. newly graduated students and researchers) as well as up-skilling and re-skilling of already working people in Regulatory Affairs or related areas. Several companies act globally, and the availability of expertise is often a decisive factor of where a business should be located. The availability of expertise is central to Sweden’s life science strategy, which states that Sweden should be a leading life science nation. In the current situation, companies are competing for skills and the shortage risks hampering development in the pharmaceutical field and thus delaying patients’ access to medicines.”
Astra Zeneca
Anne Litzén Forsman, Executive Director Regulatory Affairs Management
“This is a very important educational initiative for AstraZeneca. We are constantly seeking academic talent with regulatory affairs experience for different areas of our business in Gothenburg, Södertälje, and Stockholm. This type of education, although available in many other countries, does not currently exist in Sweden.”
Naturvetarna
Marita Teräs, Assessor
”As a union, we have initiated this training to strengthen our members’ career opportunities. Life science is the dominant sector for our members and we want to make it possible for more people to equip themselves with the required skills.”
Aptio Group
Mikael Apitzsch, Vice VD
”We wish to contribute with our expertise and experience to strengthen the industry with more employees who can work and assist in Regulatory Affairs”
Marie Gårdmark, CEO and Senior Advisor
”Navigating the regulatory landscape is a key capacity in product development”
The Swedish Medical Products Agency participates in some of the included courses.